A hydrosoluble, adjuvant-active mycobacterial “polysaccharide—peptidoglycan”. Preparation by a simple extraction technique of the bacterial cells (strain Peurois)  by Migliore-Samour, Danièle & Jollès, Pierre
Volume 25, number 2 FEBS LETTERS September 1972 
A HYDROSOLUBLE, ADJUVANT-ACTIVE MYCOBACTERIAL 
“POLYSACCHARIDE-PEPTIDOGLYCAN”. PREPARATION BY A SIMPLE 
EXTRACTION TECHNIQUE OF THE BACTERIAL CELLS (STRAIN PEUROIS)” 
Danikle MIGLIORE-SAMOUR and Pierre JOLL& 
Laboratory of Biochemistry, University of Paris VI, 
96, Bd. Raspail, Paris 6, France 
Received 23 June 1972 
1, Introduction 
Mycobacteria possess several important biological 
properties as an adjuvant effect in antibody formation 
(Freund’s adjuvant effect) [I] and the induction of 
experimental arthritis in rats termed adjuvant 
arthritis [2]. Cell walls from human and non human 
mycobacterial strains as well as waxes D with a 
nitrogen-containing moiety (peptido-glycolipids) 
provoke these reactions [3,4] . In the different active 
substances, a polysaccharide (Poly, mainly an arabino- 
galactan [5] ) is linked to a peptidoglycan (PA) 161. 
Poly-PA constitutes the hydrosoluble moiety which 
can be joined by ester linkages to the lipidic part 
(Lip, mycolic acids as in wax D). We studied previously 
in detail the nitrogen containing part of waxes D from 
human origin [6,7] and we could thus demonstrate 
a close relationship between the peptidoglycan of an 
active wax D and the material which constitutes the 
backbone of mycobacterial as well as other cell walls. 
Several procedures (saponification IS], acetylation 
[9] ) allowed to obtain the hydrosoluble moiety, 
but nearly all of them modified more or less the 
sugars, especially the amino sugars, as established by 
analytical methods. Only the homogenization of 
wax D in a buffer medium [lo] seemed to yield a 
“native” Poly-PA, i.e. a hydrosoluble moiety where 
the sugars remain unchanged during the preparation 
steps. Our chemical studies strengthened the view 
that wax D could be some degradation product of the 
* 16th communication on waxes D and other mycobacterial 
constituents. 
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mycobacterial cell walls [ 11,121. This enzymic 
degradation (autodigestion) might result naturally in a 
hydrosoluble moiety. This note describes briefly the 
preparation and partial purification of such a hydro- 
soluble adjuvant-active fraction from mycobacterial 
cells. 
2. Materials and methods 
2.1. M. tuberculosis var. hominis, strain Peurois, was 
obtained from the Pasteur Institute, Paris. The bac- 
terial residues were prepared and their lipids eliminated 
according to Aebi et al. [13] . 
2.2. Preparation of the hydrosoluble adjuvant 
Water-extraction of the Mycobacteria: the bacterial 
residues from which the lipids have been removed 
were submitted to a procedure analogous to that used 
by Wilhelm [ 141 for the isolation of proteins from 
human and animal tissues. 100 g were ground and 
homogenized in SO0 ml water with an Ultra-Turrax. 
After stirring during 5 hr at 20” and centrifugation 
(4000 rpm at 4”), the supernatant was heated to 80”; 
ammonium sulfate was added until 40% saturation. 
After 12 hr at 4’ and centrifugation, a precipitate 
(P,,) was obtained and to the supernatant set at 20°, 
ammonium sulfate was again added until 70% satura- 
tion. After 12 hr at 4” and a final centrifugation, a 
precipitate (P,,,) and a supematant (S,,) were 
recovered. P4e, P,e and S,, were exhaustively 
dialyzed against distilled water and lyophilized. 
Further purification was achieved by chromato- 
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Adjuvant activity [4] and arthrogenicity [161 of wax D of human strains and of their hydrosoluble moieties, Poly-PA, obtained 
Substance obtained from 
M. tuberculosis var. 
hominis 
Controls 
Wax Dpss * strain Peurois 
Poly-PA (after saponifi- 
cation of wax Dp,, *, 
strain Peurois) 
Poly-PA (after homogen- 
isation of wax DPT*, 
strain Ha,RvSr) 
“Native” Poly-PA from 
delipidated bacterial 
residues of strain Peurois 
by different methods. 
___-- 
Adjuvant activity to ovalbumin in 
guinea-pig 
Dose 
(ng) 
Cutaneous 
Number of reaction at 
animals 24 hr** 
Tested Positive 2 t&g) 10 (/lg) 
16 0 0 0 
200 7 7 17.4 21.1 
200 7 7 7.1 9.8 
200 8 8 11.3 15.6 
100 8 8 8.8 12.9 250 6 0 
- 
_._ 
* For details, see [4]. 
** Mean diameter of papula (mm). 
*** Severity: i++++: arthritis with malformation and ankylosis of the articulations. 
graphy on DEAE-cellulose (Whatman DE 3 2) 
equilibrated with a 0.05 M phosphate buffer pH 7 
and with a 0.05 M sodium citrate buffer pH 3 as 
eluent as well as by filtration on Biogel P 10 with 
water as eluent. The fractions were monitored at 220 
and 280 mn. 
2.3. Characterization of the various constituents 3. Results 
The amino acid and amino sugar compositions 
were established with an autoanalyzer after total 
hydrolysis (6 N HCl; 110” ; under vacuum) of 18 hr 
and 6 hr, respectively. The neutral non amino sugars 
were determined after hydrolysis (2 N HCl; 1 hr; 110”) 
qualitatively by paper chromatography (Whatman No. 
1; solvent: n-butanol-pyridine-water, 6:4:3, v/v/v) 
and quantitatively by column chromatography with a 
Technicon sugar Autoanalyzer. The lipids were in- 
vestigated by thin-layer chromatography on silica gel 
after total acid hydrolysis and ether extraction. 
3.1. Preparation of different hydrosoluble fractions 
and localisation of the Poly-PA 
By a water extraction of the cells of strain Peurois, 
1.2% P,,, 1.4% P,, and 0.9% S,, were obtained. 
Analytical studies allowed to establish the presence 
of the characteristic constituents of a Poly-PA in 
fraction S,, (Ala:Glu:DAP:NAcGlc:N-glycolylMur, 
3:2:2:2:2 (molar ratios); presence of Gal and Ara). 
Experimental polyarthritis in rat 
Dose 
(fig) 
Number of 
animals 
With 
Tested 
arthritis 
Severity*** 
250 8 8 8+++++ 
2.4. Biological activities 
Adjuvant activity was determined according to 
White et al. [4] with a cutaneous reaction to oval- 
bumin [ 151 ; the arthrogenicity was characterized fol- 
lowing Bonhomme et al. [ 161. 
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o. -0 o D.D.at 280 nm 
Fig. 1. Chromatography on DEAE-cellulose (62 X 2.5 cm) of fraction S 70 (500 mg) obtained by water-extraction of mycobacterial 
cells, strain Peurois (see Methods). 
3.2. Further purification of Po+PA (S,,) 
Fig. 1 indicates the further purification of 500 mg 
S,, from strain Peurois on DEAE-cellulose. Eight 
peaks (I-VIII) were characterized. Peaks III and IV 
contained the Poly-PA; they were separately sub 
mitted to filtration on Biogel P-10. Two fractions 
could again be obtained: one (a) containing mainly a 
polysaccharide (poly-glucose) and the other(b) cor- 
responding to the Poly-PA. 
3.3. Analytical data concerning the Poly-PA 
The sedimentation constant S,, of the hydro- 
soluble Poly-PA (S,,), peak III/b, was 1.9 compared 
to 0.65 for PA obtained by acetylation and around 2 
for Poly-PA obtained by saponification, The amino 
acid and amino sugar contents were 6.2 and 7%, 
respectively. On the basis of 3 residues of Ala/mole, 
a molecular weight of 14,800 was calculated. The 
neutral reducing sugars (Ara, Gal, Man) constituted 
the remaining part of S,,, as the lipid content was 
lower than 0.5%. 
All these analytical data are in favour of a close 
relationship between the hydrosoluble Poly-PA 
described in this note and the Poly-PA obtained by 
saponification of wax D [7]. 
3.4. Biological activity of the hydrosoluble Poly-PA 
(15, I6/ 
Table 1 indicates that the “native” hydrosoluble 
Poly-PA obtained by our mild extraction technique 
possessed an adjuvant activity when added to Freund’s 
incomplete adjuvant with an antigen (ovalbumin). The 
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hydrosoluble fractions previously obtained by 
chemical procedures were not regularly active, 
probably because the sugars were more or less 
modified. Our “native” Poly-PA did not elicit the 
arthritis-inducing effect observed with wax D. 
4. Conclusion 
This note describes the preparation by a mild 
extraction technique of a hydrosoluble adjuvant-active 
substance (polysaccharide-peptidoglycan) from the 
cells of the human mycobacterial strain Peurois. These 
studies were achieved quite independently from those 
just reported by Adam et al. [ 171 ; their hydrosoluble 
polysaccharide fraction was obtained by a different 
procedure requiring the preparation of purified cell 
walk (from M. smegmatis) which were further digested 
by hen lysozyme. Previously Misaki et al. [ 181 also 
used cell walls (strain BCG) for the preparation of a 
mucopeptide obtained by pronase digestion, capable 
of eliciting resistance of mice to staphylococcal in- 
fection but failing to induce or provoke the delayed 
hypersensitivity. 
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